Private market push in focus as BlackRock hosts investor day
NEW YORK, June 12 (Reuters) - BlackRock (BLK.N), opens new tab will hold an investor day on Thursday that is expected to provide insight into the asset management firm's strategic priorities and its growing focus on private markets.
The world's largest asset manager, overseeing $11.58 trillion as of the end of the first quarter, last year expanded its presence in private markets through a series of acquisitions that BlackRock's boss Larry Fink said were transformational for the New York-based firm.
BlackRock spent about $25 billion in 2024 on infrastructure investment fund Global Infrastructure Partners and private credit business HPS Investment Partners. It also struck a $3.2 billion deal to acquire UK data provider Preqin. That acquisition officially closed in March this year.
"I think investors are going to want more granular details and more color on BlackRock's strategy to increase exposure to alternative assets," said Cathy Seifert, an analyst at CFRA Research who covers BlackRock.
BlackRock declined to comment on the focus of its investor day.
Private assets generate significantly higher fees than exchange-traded funds (ETFs), a core part of BlackRock's business through its iShares franchise.
In his 2025 annual chairman's letter to shareholders, BlackRock's Chairman and CEO Fink said protectionism had returned with force as a result of a wealth divide that could be countered by offering more investors access to high-return private markets such as infrastructure and private credit.
Ben Budish, an analyst at Barclays, said he expected updates from the company on potentially creating indexes based on private markets after the acquisition of private markets data provider Preqin.
"Looking at what BlackRock did with iShares and ETFs, is there a way to do that with private markets? … I'm sure there's more details to come on that," he said.
Private credit, where non-bank institutions lend to companies, has experienced significant growth in recent years due to stricter regulations that have increased the cost for traditional banks to fund higher-risk loans.
But broader market volatility caused by U.S. President Donald Trump's aggressive stance on tariffs has led to slower dealmaking in private markets in general, raising some concerns there may be a mismatch between money available for private lending and not enough places to invest it.
Investors may also look for any signs regarding succession at the firm. Fink, 72, has led BlackRock since co-founding it in 1988. A recent wave of senior executive departures has reignited speculation about his eventual successor, even as Fink has signaled no immediate plan to step down.
"The firm would do itself a favor by highlighting the depth and breadth of their management bench, particularly since the company's business model is expanding and potentially becoming more complex," said Seifert.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Reuters
29 minutes ago
- Reuters
Eli Lilly's experimental obesity drug shows over 11% weight loss in early trial
June 13 (Reuters) - Eli Lilly's (LLY.N), opens new tab experimental obesity drug, eloralintide, helped some patients lose 11.5% of their body weight at 12 weeks in an early-stage study, an investor note by brokerage Cantor Fitzgerald showed on Friday. The 12-week result was published in an abstract ahead of the American Diabetes Association conference in Chicago, the brokerage said. Cantor analyst Prakhar Agrawal said the data on eloralintide looked strong in terms of weight loss and safety, adding that expectations for the drug had been low. The drug belongs to a class of medicines that mimic the pancreatic hormone amylin, which is co-secreted with insulin. Amylin slows digestion and suppresses hunger. Mid-stage trials are ongoing, both as a standalone treatment and in combination with Lilly's blockbuster GLP-1 drug, tirzepatide, sold as Zepbound. The first wave of obesity drugs focused mainly on the gut hormone GLP-1, but drugmakers are now looking for medicines that target other hormones or help preserve muscle mass during fat-loss for their next generation of drugs. We think the data today is a sign that the real successor to tirzepatide is the tirzepatide-eloralintide combo, said Jefferies analyst Akash Tewari. In March, Roche (ROG.S), opens new tab acquired the rights to Zealand Pharma's long-acting amylin analogue, petrelintide, in a collaboration valued at up to $5.3 billion. Similarly, Novo Nordisk ( opens new tab is banking on a dual mode of action involving amylin for its next generation of drugs, with experimental compounds called amycretin and CagriSema, while AstraZeneca (AZN.L), opens new tab has an amylin-based obesity drug in early trials. Lilly's eloralintide weight-loss data is tracking better than Roche and Zealand's petrelintide, said Agrawal, adding the data is meaningfully better than Novo's monotherapy. Data at 12 weeks is also competitive compared to other drug classes such as GLP-1, Agrawal also said. Eli Lilly did not immediately respond to a Reuters request for comment.
Reuters
an hour ago
- Reuters
Trump urged EchoStar, FCC chair to cut a deal on spectrum -Bloomberg
WASHINGTON, June 13 (Reuters) - President Donald Trump urged EchoStar Corp (SATS.O), opens new tab Chairman Charlie Ergen and Federal Communications Commission Chair Brendan Carr to reach a deal over the fate of the company's wireless spectrum licenses, Bloomberg reported on Friday. EchoStar shares were up 52% in after-hours trading Friday on the report. On Thursday, Trump met with Ergen and he telephoned Carr, who came to the White House to join the meeting, Bloomberg reported. The White House and EchoStar declined to comment. The FCC did not immediately respond to a request from Reuters for comment on Friday. EchoStar has been trying to shield its cache of wireless spectrum licenses from the threat of revocation by the FCC. U.S. satellite TV provider DirecTV terminated its agreement to acquire EchoStar's satellite television business last year, which includes rival Dish TV, over a failed debt-exchange offer. In May, the FCC told EchoStar it was investigating the company's compliance obligations to provide 5G service in the U.S., questioning EchoStar's buildout extension and mobile-satellite service. EchoStar said the FCC disclosure was "harming EchoStar's ongoing deployment and threaten its viability as a wireless provider as well as endanger the video and broadband satellite services upon which millions of consumers rely." The company added "the possibility of reversing prior grants of authority related to spectrum for which EchoStar paid billions and in which it invested billions more, in contravention of long-standing commission precedent." EchoStar has previously disclosed that it missed roughly $500 million in interest payments, citing uncertainty around the ongoing FCC review.
Reuters
an hour ago
- Reuters
Exclusive: White House reviews SpaceX contracts as Trump-Musk feud simmers, sources say
WASHINGTON, June 13 (Reuters) - The White House earlier this month directed the Defense Department and NASA to gather details on billions of dollars in SpaceX contracts following the public blowout between President Donald Trump and billionaire Elon Musk, four people familiar with the order told Reuters. Sparking an ongoing review, the administration ordered the agencies to scrutinize Musk's contracts to ready possible retaliation against the businessman and his companies, these people said. As Reuters reported on Thursday, Pentagon officials are simultaneously considering whether to reduce the role that SpaceX , Musk's space and satellite company, may win in an ambitious new U.S. missile defense system. Reuters couldn't determine whether the White House intends to cancel any of the approximately $22 billion in federal contracts SpaceX now has. But the review shows the administration is following through on a threat by Trump during his spat with Musk last week to possibly terminate business and subsidies for Musk ventures. 'We'll take a look at everything,' the president said, speaking to reporters aboard Air Force One on June 6. In an email to Reuters, a White House spokesperson didn't answer questions about Musk's business, saying the 'Trump administration is committed to a rigorous review process for all bids and contracts.' In a separate statement, a spokesperson at NASA said the agency 'will continue to work with our industry partners to ensure the president's objectives in space are met.' Neither SpaceX nor officials at the Defense Department responded to requests for comment. The people familiar with the order said the contract scrutiny is intended to give the administration the ability to move fast if Trump decides to act against Musk, who until recently was a senior advisor to the president and the head of the cost-cutting Department of Government Efficiency, or DOGE. The review is 'for political ammunition,' one of the people said. Whether the U.S. government could legally, or practically, cancel existing contracts is unclear. But the possibility underscores concerns among governance experts that politics and personal pique could improperly influence matters affecting government coffers, national security and the public interest. 'There's an irony here that Musk's contracts could be under the same type of subjective political scrutiny that he and his DOGE team have put on thousands of other contracts,' said Scott Amey, a contracting expert and general counsel at the Project on Government Oversight, a watchdog group based in Washington. 'Any decision shouldn't be based on the egos of two men but on the best interests of the public and national security.' Musk's SpaceX in recent years has become a crucial partner of the U.S. government in much of its aerospace and defense work – launching satellites and other space cargo and potentially managing a crucial element of the 'Golden Dome' missile shield planned by Trump. Although Musk in recent days has sought to walk back some of his critiques of the president – such as calling for Trump's impeachment last week and linking him to a convicted sex offender – his outbursts nonetheless highlighted the government's reliance on SpaceX. Before reversing course, Musk threatened to decommission the company's Dragon spacecraft. The spacecraft, as part of a roughly $5 billion contract with NASA, is the only U.S. vessel currently capable of carrying astronauts to and from the International Space Station. SpaceX is also building a network of hundreds of spy satellites under a classified contract with the National Reconnaissance Office, a U.S. intelligence agency. The contract was a pivotal transaction for SpaceX, deepening its ties with U.S. defense and intelligence services.
